Millstone CEO Karl Neuberger on the readiness work OEM teams cannot afford to treat as an afterthought, and why “one PO” changes how complex programs perform.
From legacy brands to a unified vision, CEO Olivier Wolber shares how EXALTA’s integration is unlocking new value for customers worldwide.
Dr. Adrian Cohen shares how his journey from sports fields and rescue helicopters led to Headsafe’s groundbreaking technology, transforming how we diagnose concussions worldwide.
Trusted by 500 institutions and 2,500 surgeons, AROSurgical shows what focus on quality and service can achieve.
Smart Step Surgical is tackling one of the OR’s most overlooked frustrations, turning a simple idea into a game-changing solution for surgeons, nurses, and staff alike.
Why Europe’s shifting regulatory landscape, global trade tensions, and startup survival strategies matter more than ever.
At The MedTech Digest, we believe in spotlighting the founders and technologies shaping the future of
healthcare. Our team at MedTech Momentum is honored to support XLTA as you bring XLTA®
Hydrocapillary Triple-Action™ technology to the U.S. market.
Some of the most innovative leaders in the Medical Technology industry don’t arrive there through a straight line, and that’s certainly the case with Brian Kieser. Before founding Nvision Biomedical Technologies and building one of the most integrated innovation ecosystems in the industry, Brian was a mechanical engineering student, then an accountant, and eventually a certified public accountant (CPA) at KPMG. From technical schematics to financial audits, he’s seen every layer of how a business is built successfully.
We sit down with Brian More, CEO of Nanovis, for a candid conversation on strategy, science, and scaling up smart. From startup grit to a groundbreaking collaboration with Medtronic, Brian shares how Nanovis is transforming orthopedic and spinal implants through surface-level innovation, and why staying focused is the key to long-term success.
Founded as a spin-out from the University of Oxford, Brainomix has already transformed stroke care across Europe. With more than 70% market share in the UK and over 60 peer-reviewed publications validating its efficacy in real world settings, the company has delivered what few others can: evidence-based, scalable AI that improves outcomes and makes stroke systems more efficient.
